Search

everythinglearnresearchcommunity

for

Search:↓

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The role of γδT-cells in causing alopecia areata remains unclear.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Higher inflammation markers are linked to more severe alopecia areata.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

New genetic discoveries in alopecia areata could lead to better treatments.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Arg1+ macrophages may play a role in causing alopecia areata.